Ucar, B. Et Al. 2021. A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2. NANOTECHNOLOGY , vol.32, no.48 .

Ucar, B., Acar, T., Pelit Arayıcı, P., & Derman, S., (2021). A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2. NANOTECHNOLOGY , vol.32, no.48.

Ucar, Burcu Et Al. "A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2," NANOTECHNOLOGY , vol.32, no.48, 2021

Ucar, Burcu Et Al. "A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2." NANOTECHNOLOGY , vol.32, no.48, 2021

Ucar, B. Et Al. (2021) . "A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2." NANOTECHNOLOGY , vol.32, no.48.

@article{article, author={Burcu Ucar Et Al. }, title={A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2}, journal={NANOTECHNOLOGY}, year=2021}